ARB204
/ Arbele
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 06, 2024
A novel CDH17/PD-1 bispecific antibody for treatment of advanced gastrointestinal cancers
(AACR 2024)
- "This bispecific design allowed selective T-cell mediated killing on cancer cells expressing CDH17, mitigating the risk of off-tumor toxicity. ARB204 warrants further studies on its immune checkpoint inhibition in animal models."
IO biomarker • Metastases • Gastrointestinal Cancer • Oncology • Solid Tumor • CDH17
1 to 1
Of
1
Go to page
1